Frontline Healthcare & Communities

  • GRI

  • J&J22-10,

    Strengthening health systems through Health for Humanity 2025 Goals

  • 413-1

    Operations with local community engagement, impact assessments, and development programs

In line with our commitment to advancing public health, we invest extensively in raising the quality of health and well-being in the communities in which we live and work.

Johnson & Johnson’s Global Community Impact (GCI) organization —with funding from Johnson & Johnson Foundation, the Corporation and operating companies across the Johnson & Johnson Family of Companies—drives our community-giving initiatives around the world. Aligned with our ESG strategy, and our Health for Humanity 2025 Goals, as well as driving our ORTHE initiative, GCI specifically advances initiatives at the front line of healthcare with an ambitious public goal.

Health for Humanity 2025 Goals
View Scorecard
SDG 3 - Good Health and Well-Being (icon)SDG 5 - Gender Equality (icon)SDG 8 - Decent Work and Economic Growth (icon)SDG 17 - Partnerships for the Goals (icon)
Progress in Supporting Frontline Health Workers (by 2030)

  • Reached more than 570,000 nurses, midwives and community health workers in 2022, supporting over 1,300,000 frontline health workers in cumulative total.

Exceeded

Supporting frontline health workers

We believe that if we solve the challenges facing frontline health workers, we will improve healthcare for everyone. The Johnson & Johnson Center for Health Worker Innovation (“the Center”), established in 2019, is tasked with guiding our $250 million commitment to support frontline health workers, with a goal of supporting one million nurses, midwives and community health workers by 2030. Although we exceeded our one million goal in 2022, well in advance of our plan, we continue the work of the Center to provide critically needed support for community health workers.

In 2022, the Center advanced several initiatives, including:

Supporting community health workers across Africa

A professionalized workforce of community health workers, who engage daily with communities, is key to responding to disease outbreaks and making gains on longstanding global health priorities, including universal health coverage. The Africa Frontline First Catalytic Fund (AFF-CF) was launched in 2022 to support community health workers in 10 African countries with a $15 million commitment by the Johnson & Johnson Foundation and a $10 million commitment by the Skoll Foundation. These investments will be matched by The Global Fund to fight AIDS, TB and malaria. The AFF-CF will help accelerate progress and improve healthcare delivered at the community level, as well as ensure the women, who make up the large proportion of community health workers, are properly paid for their work. The Fund aims to triple the number of salaried community health workers in sub-Saharan Africa, expanding coverage to 100 million people by 2030.

Health workers are the cornerstone of care. By training, empowering and integrating community health workers into existing health systems, it’s possible to extend care and reduce the burden of disease for millions of people. Our investment in the African Frontline First Catalytic Fund builds on more than 125 years of supporting health workers, especially in resource-limited settings.

Lauren Moore

Vice President, Global Community Impact, Johnson & Johnson

Strengthening community-based health systems

The Center helped establish a Community Health Worker Think Tank, led by South Africa’s National Department of Health, to address critical gaps facing community health worker policy implementation and community-level service delivery. In Nigeria, the Center collaborated widely internally and externally to help create a roadmap of partnership opportunities to strengthen the nursing and midwifery workforce in Nigeria with an emphasis on mental health, oncology, and maternal and newborn health. Also, the Center launched Basecamp for Health System Transformation with the School of System Change, a pilot program to nurture system change practitioners to build community health system capacity across Europe and sub-Saharan Africa.

Harnessing the power of data

To support frontline health workers in making trusted, data-driven decisions, the Center supported several thousand hours of pro bono data science services in sub-Saharan Africa and leveraged data sets of millions of health encounters generated by more than 4,000 community health workers to improve data quality and inform best practices. The Center is collaborating with DataKind and community-based organizations to champion data collection practices that will enable health systems stakeholders to make healthcare delivery decisions backed by trusted data.

Helping health workers manage stress

To support health workers in managing stress, exacerbated during the COVID-19 pandemic, The Resilience Collaborative, the Center’s global learning community launched in 2021, grew to more than 600 members in 2022. Open-source resources, now including Spanish, Portuguese and Hindi translations, are being accessed by more than 300 organizations in 38 countries and assisting in raising awareness about ways to implement and evaluate evidence-based programs for improved health worker resilience and well-being.

Supporting supply chain training for health workers in Africa

Johnson & Johnson provided funding to Empower School of Health to develop a free, online supply chain training curriculum that aims to help frontline health workers understand their role in the supply chain and delivery of essential medicines and treatments. Empower School of Health delivered this training with the East, Central and Southern African College of Nursing and the Ecumenical Pharmaceutical Network. After a successful pilot in Botswana and Kenya in 2022, the curriculum is currently being rolled out in three additional countries in 2023: Nigeria, Rwanda and South Africa.

Enhancing HCP education around the world

J&J MedTech partnered with Advances in Surgery and other industry associations to provide more than 1 million HCPs with online webinars across a range of topics and specialties. For example, a DEI series of 12 webinars was dedicated to discussing workplace challenges and best practices, and a Resilient Resident Series of 14 webinars targeted leading surgeons in their early career. Overall, the suite of webinar series attracted more HCPs in 147 countries across more than 70 events.

Wilson M. Aloubia, M.D., MSc., and LaDonna Kearse, M.D., practice their laparoscopic skills in a surgical training lab during Diverse Surgeon Initiative 2.0. (photo)
Wilson M. Aloubia, M.D., MSc., and LaDonna Kearse, M.D., practice their laparoscopic skills in a surgical training lab during Diverse Surgeon Initiative 2.0.

Ethicon reignited its partnership with the Society of Black Academic Surgeons by expanding the Diverse Surgeons Initiative (DSI), a program focused on equipping promising minority surgical residents for fellowship attainment and faculty appointment. The DSI supported clinical and technical training and mentorship for 14 surgical residents and will continue into 2023 to help them realize their potential as future surgical fellows and faculty leaders. Of DSI participants from prior cohorts, 87% completed subspecialty fellowships and 41% obtained faculty positions following the next five years of their careers.

Championing nurses

Johnson & Johnson has proudly championed the nursing profession for more than a century. With innovative mindsets, invaluable insights and hands-on experience, nurses make healthcare systems work: When we work together to support nurses, we are advancing better healthcare for all. Our goal is to work with like-minded partners to attract and strengthen a thriving, innovative and diverse nursing workforce, empowered to advance health equity and transform healthcare. We support and empower nurses through advocacy, scholarships, clinical and leadership education, events that teach and hone healthcare innovation skill sets, mental health resources and more.

Our work includes advocating for the fundamental value of the nursing profession, catalyzing a workplace culture and environment where nurses can thrive and strengthening diversity in nursing. We bring greater awareness to the extraordinary impact that nurses have in healthcare through key activities and programs, including TV and social media advertising, storytelling on our “See You Now” podcast and through Notes on Nursing. We are working to spark interest in the profession among diverse, prospective nursing students through a new series called The Future of Nursing is Me.

We also support events like NurseHack4Health that support nurse-led innovation in healthcare. Working in collaboration with SONSIEL and Microsoft, we launched our first Pitch-A-Thon to elevate and foster nurse-led ideas for redesigning a healthy work environment where the workforce can thrive. Nearly 40 nurse-led, interdisciplinary health systems applied to the Pitch-A-Thon, and 10 were selected as finalists. Representing the transformative power of nurse-led innovation, three teams were awarded $260,000 in grant funding to bring their solutions to life.

Accelerating health equity entrepreneurship

Johnson & Johnson Impact Ventures (JJIV) is a $50 million impact fund within the Johnson & Johnson Foundation that invests in healthcare companies and entrepreneurs with innovative business models to improve health equity and access to affordable and quality care for under-resourced patients around the world. Financial returns from portfolio companies are reinvested, enabling further expansion of the fund’s impact. JJIV also leverages Johnson & Johnson’s network of experience and expertise in healthcare to provide resources, support and guidance to its portfolio companies.

Working with the JJIV team has allowed us to improve our thoughtfulness of how we create a business where impact outcomes are inextricably linked … the bigger we are as a business, the more impact we achieve.

Farouk Meralli

Founder and CEO of SwipeRx

Progress was made in 2022, with new investments and approximately half of the $50 million fund having now been committed to companies across five continents. Since joining the portfolio, these companies have reached 2.8 million patients directly and supported more than 61,000 HCPs.

Supporting the field

Fueled by the belief in the potential of market-based solutions to address health equity issues, JJIV provided funding to early stage health impact entrepreneurs to develop their ideas through various external partnerships and programs. JJIV also provided funding for Rock Health’s Equitable Investments Initiative to further research and publish a call-to-action report for greater investment in underrepresented entrepreneurs in the U.S. Additionally, JJIV helped fund the development of IRIS+, an investment tool from the Global Impact Investing Network to assist investors to identify and support enterprises combating racial health disparities.

2022 was a milestone year for JJIV, with a first return on investment from Patients Know Best, a personal health record company that is helping to give patients control of their own medical information.

Our giving

As the largest, most diversified healthcare products company, Johnson & Johnson is an essential part of the fabric of society in communities around the globe. We care deeply about the well-being of our communities, and we use our reach and share our resources with communities around the world, through collaborations and partnerships, to forge a healthier, more equitable future for all.

Our Giving (Millions)*

Products contributed Cash contributed 2020 2021 2022 $2,567 $2,738 $4,292 2020 2021 2022 Cash contributed Products contributed $2,567 $2,738 $4,292
* This chart includes Enterprise giving, including disaster relief, and the value of products donated by Janssen to JJPAF. The significant increase in our giving was attributed to product donations to JJPAF.

Our community giving can be categorized into three channels:

Foundation

The Johnson & Johnson Foundation is a registered charitable organization that is funded solely by the Johnson & Johnson Family of Companies. The Foundation operates worldwide as Johnson & Johnson Foundation United States (founded 1953) and Johnson & Johnson Foundation Scotland (founded 2007). These independent entities support region-specific and global partnerships and initiatives, employee volunteering and disaster response activities. Specific initiatives supported by the Foundation mentioned in this Report include the Center for Health Worker Innovation and Johnson & Johnson Impact Ventures.

Enterprise

Across Johnson & Johnson, both at the Enterprise level and through our operating companies in more than 60 countries of the world, we donate funds and products to regional or local causes aligned with Our Credo, Our Purpose and specific needs in local communities, including disaster relief. These donations are at the discretion of local Johnson & Johnson leaders and globally amount to hundreds of millions of dollars each year.

Patient Assistance

In the U.S., we support independent initiatives by donating medicines and funding to the Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF), an independent nonprofit that helps eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies.

Disaster preparedness & relief

We continue to work with trusted partners, including Americares, Heart to Heart International, the Catholic Medical Mission Board, MAP International, MedShare and International Health Partners, on the front lines of care by coordinating product donations and supporting programs that help communities recover, rebuild and become resilient. In the immediate aftermath of major disasters, we provide essential Pharmaceutical, MedTech and Consumer Health products, as well as monetary donations and other support.

$ 23.20  million

The value of Johnson & Johnson products provided to communities impacted by natural disasters around the world in 2022.

$ 10.35  million

Funding provided for the readiness and immediate, mid- and long-term response to natural disasters in 2022.

In 2022, building on a 15-year collaboration, Johnson & Johnson and International Health Partners (IHP) debuted a shared global donation platform that harnesses best practices and scale to help communities in crisis recover, rebuild and regain resilience after disasters. The technology behind this unified global system for product donation will be extended to all Johnson & Johnson’s and IHP’s approved product donations partners. By offering increased visibility and alignment, as well as a streamlined, automated approvals system, this innovative technology is improving the speed of product donations across geographies.

Examples of our support for communities struck by disaster or humanitarian crises in 2022 include:

  • War in Ukraine: We contributed more than $32 million overall to relief efforts, including cash and product donations in compliance with current international sanctions. Our donations included both humanitarian support for refugees with a combined $10 million to the International Rescue Committee and International Federation of Red Cross and Red Crescent, as well as products valued at more than $22 million, including medical devices, essential medicines and consumer health products such as first-aid and feminine-hygiene products.
  • Hurricanes Fiona and Ian: We partnered with Americares and Gulf Coast Community Foundation to address immediate needs and restore health services in areas affected by Hurricane Ian in central Florida and Hurricane Fiona in Puerto Rico.

Heart to Heart International volunteer Kathi Kehmna, nurse practitioner, helps her young patient feel at ease while receiving medical treatment in the aftermath of Hurricane Ian. Heart to Heart International's disaster response team provided free healthcare services in Arcadia, Florida, U.S., in October 2022. (photo)
Heart to Heart International’s disaster response team provided free healthcare services in 2022.

Examples of our support for communities struck by disaster or humanitarian crises in 2022 include:

  • Volcano in Tonga: We worked with UNICEF to address the needs of children and caregivers, following the eruption of the underwater volcano Hunga Tonga Hunga Ha’apai, which blanketed the majority of Tonga with volcanic ash, affecting nearly 80% of Tonga’s population and displacing more than 1,525 people, including more than 500 children.
  • Flooding in Kentucky: We joined with Americares in the aftermath of the devastating flooding that struck southeastern Kentucky to help restore health services at three clinics and support people displaced from their homes.
  • Earthquake in Indonesia: Following the earthquake that struck West Java, Indonesia, displacing more than 100,000 people, we provided, together with Project Hope, 10 community-managed latrines with water tanks in two villages offering access to clean water and sanitation facilities.

DEI
Diversity, equity and inclusion
ESG
Environmental, social and governance
GCI
Global Community Impact
HCP
Healthcare professional(s)
J&J MedTech
Johnson & Johnson MedTech
ORTHE
Our Race to Health Equity
TB
Tuberculosis